Virtopsy Market Report 2026

The virtopsy market size has grown rapidly in recent years. It will grow from $1.45 billion in 2025 to $1.7 billion in 2026 at a compound annual growth rate (CAGR) of 17%. The growth in the historic period can be attributed to increasing adoption of non invasive autopsy methods, growing demand for accurate forensic investigations, rising use of advanced medical imaging systems, expanding need for faster post mortem procedures, increasing preference for body preservation in autopsy practices.

The virtopsy market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to growing integration of artificial intelligence in virtual autopsy, rising demand for digital forensic documentation, expanding deployment of high resolution imaging technologies, increasing investment in healthcare digitization, growing emphasis on efficient forensic workflow automation. Major trends in the forecast period include advancements in three dimensional imaging technologies, innovations in artificial intelligence based forensic analysis, developments in robotic scanning systems, research and development in digital pathology tools, advancements in integrated forensic data management systems.

The rising demand for non-invasive forensic investigations is expected to drive the growth of the virtopsy market in the coming years. Non-invasive forensic investigations involve imaging-based methods such as CT scans and MRI that allow examination of bodies or evidence without physical dissection or tissue damage, thereby preserving integrity for analysis. This growing demand is largely driven by the need to maintain the original condition of the body or evidence during forensic examinations. Virtopsy supports non-invasive forensic investigations by using advanced imaging technologies, including CT and MRI, to assess bodies without conventional autopsy procedures. It enhances investigative accuracy, preserves evidence, and reduces procedural risks. For instance, in November 2024, according to the National Institute of Justice, a US-based research and evaluation agency within the Department of Justice, the New Mexico Office of the Medical Investigator performs CT scans on nearly all incoming cases, reducing full autopsy rates from 80-85% to around 50% while still managing approximately 4,500 cases annually. Therefore, the increasing demand for non-invasive forensic investigations is contributing to the growth of the virtopsy market.

The shortage of trained forensic pathologists is also expected to propel the growth of the virtopsy market going forward. Forensic pathologists are specialized medical professionals responsible for determining causes of death through post-mortem examinations and supporting legal investigations. The shortage is primarily driven by the extensive training, expertise, and workload required to perform traditional autopsies and interpret complex post-mortem findings. Virtopsy helps address this shortage by enabling detailed post-mortem analysis through imaging technologies that reduce reliance on highly specialized manual expertise. This approach improves efficiency and accessibility while maintaining high levels of diagnostic accuracy. For example, in November 2025, according to the Australian Government Department of Health, a government health agency, chemical pathology is projected to face a 48% workforce shortfall by 2037, while forensic pathology shortages are expected to increase from 8 full-time equivalents (14%) in 2027 to 18 full-time equivalents (29%) by 2037. Consequently, the shortage of trained forensic pathologists is supporting the expansion of the virtopsy market.

The growing investment in digital healthcare infrastructure is further expected to fuel the growth of the virtopsy market. Digital healthcare infrastructure includes the adoption of advanced imaging systems, data management technologies, and integrated digital platforms within medical and forensic environments to enhance diagnostics and case management. Increased investment in this infrastructure is driven by rising demand for AI-enabled solutions, improved data integration, and efficiency gains amid escalating healthcare costs worldwide. Virtopsy aligns with digital healthcare infrastructure by leveraging high-resolution, non-invasive imaging techniques such as CT, MRI, and 3D surface scanning to enable precise post-mortem analysis without traditional autopsies. For instance, in July 2025, according to the Association of British HealthTech Industries, a UK-based medical technology trade association, up to £600 million was allocated to expand secure health data environments through the Health Data Research Service, alongside broader investments of up to £10 billion in digital transformation and £22.6 billion annually in research and development by 2029-30. Therefore, increasing investment in digital healthcare infrastructure is driving the growth of the virtopsy market.

Major companies operating in the virtopsy market are Siemens Healthineers AG, FUJIFILM Holdings Corp., Shimadzu Corporation, Canon Medical Systems Corporation, Virtual Autopsy UK Ltd., Virtopsy Canada Inc., Alrize Global Tech Pvt. Ltd., Advanced Detection Solutions LLC, Forensic Radiology Group LLC, Thanato Group, Digital Autopsy UK, iQ IMAGE, RMS Scanning.

North America was the largest region in the virtopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the virtopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have impacted the virtopsy market by increasing costs of imported imaging hardware, high-resolution scanners, and specialized forensic software components. these effects are most pronounced in hardware-intensive segments and in regions such as europe and asia-pacific where advanced imaging systems are frequently sourced globally. higher acquisition costs may slow adoption in smaller forensic labs, while tariffs are also encouraging local manufacturing, regional system integration, and greater reliance on software-driven and cloud-based virtopsy solutions, supporting long-term market adaptability.

Virtopsy, also known as virtual autopsy, is a non-invasive post-mortem examination method that uses advanced imaging technologies such as computed tomography (CT), magnetic resonance imaging (MRI), three-dimensional surface scanning, and digital reconstruction tools to examine the body without traditional surgical dissection. It enhances forensic efficiency by preserving body integrity while delivering rapid, detailed, and reproducible post-mortem findings with improved analytical accuracy.

The primary components of virtopsy systems are hardware, software, and services. Hardware includes advanced imaging and scanning equipment used to perform non-invasive postmortem examinations and digital autopsies. These systems are based on technologies such as computed tomography, magnetic resonance imaging, three-dimensional surface scanning, angiography, and others, deployed through on-premise and cloud-based models, used in applications including forensic pathology, clinical research, education and training, veterinary forensics, and others, among end users such as hospitals, forensic laboratories, academic and research institutes, and others.

The virtopsy market consists of revenues earned by entities by providing services such as post-mortem imaging, 3D forensic reconstruction, virtual autopsy reporting, forensic analysis and documentation, digital case management, and training or consultancy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The virtopsy market also includes sales of 3D surface scanning devices, photogrammetry tools, forensic imaging accessories, and specialized software modules. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.